Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Exact Sciences names new board member
Mr Singer is CEO of The BrainScope Company, a privately held neurotechnology company. Mr Singer has held executive level positions at Revolution, where he was instrumental in the
Mr Singer is CEO of The BrainScope Company, a privately held neurotechnology company. Mr Singer has held executive level positions at Revolution, where he was instrumental in the
This initial study of 20 healthy postmenopausal female patients aged 40 to 70 years resulted in peak concentrations in the range of those obtained with the commercially available
The termination of the manufacturing and distribution agreement allows RxElite to supply anesthetic gas products to its customers from alternative sources. RxElite said that it will work closely
Uresta continence care is designed to stop bladder leakage and help women to manage their stress urinary incontinence (SUI) with a conservative alternative to traditional products and surgery.
Ocimum Biosolutions’s knowledge of computer systems validation requirements and processes as well as its understanding of pharmaceutical and biotechnology laboratories combined with Clarmon’s solution, QAvalid, is said to
Under the collaboration, fqubed will expand the scope of its Tempest high throughput experimentation platform to evaluate potential formulations for its partner’s product portfolio. Tempest is currently used
The combined solution is a fully integrated software package that consists of TomTec’s Image-Arena and Medis’s QAngio XA quantification software. It will be available as one platform that
The termination was based on the company’s determination that it no longer required the services of Dr Karlin. Dr Karlin’s responsibilities will be assumed by Robert Jager, chief
This agreement is said to be Virtual Radiologic’s first Enterprise Connect agreement outside the US, and will provide Pro-Laudo with increased efficiency and allow for rapid market penetration.
The company has reached a settlement with the US Department of Justice (DoJ)related to an investigation into the Diabetes Care division’s historical marketing programs with certain mail order